Holoxan Baxter


Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 17.6%
Drug Use For Unknown Indication 16.8%
Sarcoma 8.5%
Bone Sarcoma 6.0%
Rhabdomyosarcoma 5.1%
Testis Cancer 5.1%
B-cell Lymphoma 4.4%
Precursor T-lymphoblastic Lymphoma/leukaemia 4.3%
Non-hodgkin's Lymphoma 3.9%
Ewing's Sarcoma 3.8%
Chemotherapy 3.4%
Testicular Germ Cell Cancer 3.4%
Diffuse Large B-cell Lymphoma 3.0%
Leiomyosarcoma 2.9%
Lymphoma 2.6%
Premedication 2.3%
Hodgkin's Disease 2.2%
Hodgkin's Disease Stage Iv 1.8%
Drug Exposure During Pregnancy 1.7%
Metastases To Central Nervous System 1.4%
Encephalopathy 9.2%
Muscle Spasms 7.9%
Renal Tubular Disorder 7.9%
Vomiting 6.6%
Dysuria 5.3%
Epilepsy 5.3%
Pyrexia 5.3%
Renal Failure 5.3%
Toxic Encephalopathy 5.3%
Unresponsive To Stimuli 5.3%
Cytolytic Hepatitis 3.9%
Ejection Fraction Decreased 3.9%
Interstitial Lung Disease 3.9%
Neurotoxicity 3.9%
Neutropenia 3.9%
Pancytopenia 3.9%
Renal Failure Acute 3.9%
Thrombocytopenia 3.9%
Acute Myeloid Leukaemia 2.6%
Angioedema 2.6%
Secondary
Sarcoma 17.9%
Rhabdomyosarcoma 17.3%
Drug Use For Unknown Indication 12.6%
Product Used For Unknown Indication 9.8%
Leiomyosarcoma 7.3%
Bone Sarcoma 5.1%
Precursor T-lymphoblastic Lymphoma/leukaemia 4.0%
Diffuse Large B-cell Lymphoma 3.9%
Ewing's Sarcoma 3.9%
Lymphoma 3.3%
Chemotherapy 2.7%
Acute Lymphocytic Leukaemia 2.2%
T-cell Lymphoma 2.0%
Transitional Cell Carcinoma 2.0%
Diffuse Large B-cell Lymphoma Stage Ii 1.5%
Testis Cancer 1.2%
Metastases To Central Nervous System 1.0%
Testicular Germ Cell Cancer 0.9%
Desmoplastic Small Round Cell Tumour 0.7%
Liposarcoma Metastatic 0.7%
Muscle Twitching 16.1%
Encephalopathy 13.9%
Ejection Fraction Decreased 13.1%
Vomiting 13.1%
Intracardiac Thrombus 7.3%
Renal Failure 4.4%
Renal Impairment 4.4%
Pyrexia 3.6%
Renal Tubular Disorder 3.6%
Febrile Neutropenia 2.9%
Renal Failure Acute 2.9%
Paraesthesia 2.2%
Toxic Encephalopathy 2.2%
Cerebellar Syndrome 1.5%
Diffuse Large B-cell Lymphoma 1.5%
Epilepsy 1.5%
Infusion Site Extravasation 1.5%
Interstitial Lung Disease 1.5%
Pancytopenia 1.5%
Renal Failure Chronic 1.5%
Interacting
Non-hodgkin's Lymphoma 55.6%
Drug Use For Unknown Indication 44.4%
Pancytopenia 100.0%

Drug Data